Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
47
SMMNY Quote, Financials, Valuation and Earnings
Last price:
$26.19
Seasonality move
:
-2.66%
Day range:
$26.00 - $26.20
52-week range:
$23.28 - $30.19
Dividend yield:
3.83%
P/E ratio:
24.77x
P/S ratio:
2.28x
P/B ratio:
2.77x
Volume:
14.8K
Avg. volume:
136.7K
1-year change:
-3.96%
Market cap:
$58.7B
Revenue:
$25.8B
EPS (TTM):
$1.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
-- | -- | -- | -- | -- |
|
BNTX
BioNTech SE
|
$1.2B | $0.12 | -24.04% | -86.85% | $138.33 |
|
CVAC
CureVac NV
|
$25.1M | -$0.08 | 0.04% | -32.36% | $5.31 |
|
EVO
Evotec SE
|
$219.8M | -$0.01 | 17.8% | -75.1% | $5.4436 |
|
IFRX
InflaRx NV
|
$34.6K | -$0.14 | -74.55% | -16.09% | $11.24 |
|
IMTX
Immatics NV
|
$12.5M | -$0.45 | -81.87% | -704.25% | $18.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$26.17 | -- | $58.7B | 24.77x | $0.50 | 3.83% | 2.28x |
|
BNTX
BioNTech SE
|
$95.13 | $138.33 | $22.9B | 191.55x | $0.00 | 0% | 6.47x |
|
CVAC
CureVac NV
|
$4.31 | $5.31 | $970.5M | 6.03x | $0.00 | 0% | 11.97x |
|
EVO
Evotec SE
|
$3.1300 | $5.4436 | $1.1B | -- | $0.00 | 0% | 1.34x |
|
IFRX
InflaRx NV
|
$1.14 | $11.24 | $77.2M | -- | $0.00 | 0% | 352.24x |
|
IMTX
Immatics NV
|
$10.37 | $18.75 | $1.3B | 42.21x | $0.00 | 0% | 13.85x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
45.5% | 0.543 | 29.12% | 0.68x |
|
BNTX
BioNTech SE
|
1.31% | 1.267 | 1.22% | 6.78x |
|
CVAC
CureVac NV
|
3.87% | 1.835 | 3.39% | 1.84x |
|
EVO
Evotec SE
|
37.72% | 1.505 | 44.12% | 1.05x |
|
IFRX
InflaRx NV
|
2.1% | -0.453 | 1.26% | 2.34x |
|
IMTX
Immatics NV
|
3.78% | 2.023 | 1.86% | 6.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$2.8B | $1.1B | 6.23% | 11.65% | 14.84% | $804.3M |
|
BNTX
BioNTech SE
|
$1.6B | $743.4M | -2.96% | -3.01% | 41.89% | $785.5M |
|
CVAC
CureVac NV
|
$57.9M | -$11.6M | 19.52% | 20.55% | -18.33% | $31.6M |
|
EVO
Evotec SE
|
-$72.4K | -$59.7M | -11.62% | -17.7% | -31.17% | -$101.3M |
|
IFRX
InflaRx NV
|
-$89.2K | -$11.7M | -80.95% | -82.01% | -42057.91% | -$11.4M |
|
IMTX
Immatics NV
|
-- | -$63.9M | -24.18% | -25.21% | -1053.82% | -$56.2M |
Siemens Healthineers AG vs. Competitors
-
Which has Higher Returns SMMNY or BNTX?
BioNTech SE has a net margin of 9.44% compared to Siemens Healthineers AG's net margin of -1.89%. Siemens Healthineers AG's return on equity of 11.65% beat BioNTech SE's return on equity of -3.01%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG37.55% $0.31 $39B BNTXBioNTech SE90.24% -$0.14 $22B -
What do Analysts Say About SMMNY or BNTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $138.33 which suggests that it could grow by 46.94%. Given that BioNTech SE has higher upside potential than Siemens Healthineers AG, analysts believe BioNTech SE is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 BNTXBioNTech SE14 5 0 -
Is SMMNY or BNTX More Risky?
Siemens Healthineers AG has a beta of 1.122, which suggesting that the stock is 12.17% more volatile than S&P 500. In comparison BioNTech SE has a beta of 1.295, suggesting its more volatile than the S&P 500 by 29.477%.
-
Which is a Better Dividend Stock SMMNY or BNTX?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.83%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 31.41% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or BNTX?
Siemens Healthineers AG quarterly revenues are $7.4B, which are larger than BioNTech SE quarterly revenues of $1.8B. Siemens Healthineers AG's net income of $697.6M is higher than BioNTech SE's net income of -$33.5M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 24.77x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.28x versus 6.47x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.28x 24.77x $7.4B $697.6M BNTXBioNTech SE6.47x 191.55x $1.8B -$33.5M
-
Which has Higher Returns SMMNY or CVAC?
CureVac NV has a net margin of 9.44% compared to Siemens Healthineers AG's net margin of -5832.47%. Siemens Healthineers AG's return on equity of 11.65% beat CureVac NV's return on equity of 20.55%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG37.55% $0.31 $39B CVACCureVac NV91.57% $1.41 $1.1B -
What do Analysts Say About SMMNY or CVAC?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $5.31 which suggests that it could grow by 23.51%. Given that CureVac NV has higher upside potential than Siemens Healthineers AG, analysts believe CureVac NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 CVACCureVac NV1 3 0 -
Is SMMNY or CVAC More Risky?
Siemens Healthineers AG has a beta of 1.122, which suggesting that the stock is 12.17% more volatile than S&P 500. In comparison CureVac NV has a beta of 1.771, suggesting its more volatile than the S&P 500 by 77.063%.
-
Which is a Better Dividend Stock SMMNY or CVAC?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.83%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 31.41% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or CVAC?
Siemens Healthineers AG quarterly revenues are $7.4B, which are larger than CureVac NV quarterly revenues of $63.3M. Siemens Healthineers AG's net income of $697.6M is higher than CureVac NV's net income of $319.3M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 24.77x while CureVac NV's PE ratio is 6.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.28x versus 11.97x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.28x 24.77x $7.4B $697.6M CVACCureVac NV11.97x 6.03x $63.3M $319.3M
-
Which has Higher Returns SMMNY or EVO?
Evotec SE has a net margin of 9.44% compared to Siemens Healthineers AG's net margin of -26.29%. Siemens Healthineers AG's return on equity of 11.65% beat Evotec SE's return on equity of -17.7%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG37.55% $0.31 $39B EVOEvotec SE-0.04% -$0.14 $1.5B -
What do Analysts Say About SMMNY or EVO?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Evotec SE has an analysts' consensus of $5.4436 which suggests that it could grow by 74.58%. Given that Evotec SE has higher upside potential than Siemens Healthineers AG, analysts believe Evotec SE is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 EVOEvotec SE1 0 0 -
Is SMMNY or EVO More Risky?
Siemens Healthineers AG has a beta of 1.122, which suggesting that the stock is 12.17% more volatile than S&P 500. In comparison Evotec SE has a beta of 1.821, suggesting its more volatile than the S&P 500 by 82.079%.
-
Which is a Better Dividend Stock SMMNY or EVO?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.83%. Evotec SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 31.41% of its earnings as a dividend. Evotec SE pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or EVO?
Siemens Healthineers AG quarterly revenues are $7.4B, which are larger than Evotec SE quarterly revenues of $191.5M. Siemens Healthineers AG's net income of $697.6M is higher than Evotec SE's net income of -$50.3M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 24.77x while Evotec SE's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.28x versus 1.34x for Evotec SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.28x 24.77x $7.4B $697.6M EVOEvotec SE1.34x -- $191.5M -$50.3M
-
Which has Higher Returns SMMNY or IFRX?
InflaRx NV has a net margin of 9.44% compared to Siemens Healthineers AG's net margin of -51538.49%. Siemens Healthineers AG's return on equity of 11.65% beat InflaRx NV's return on equity of -82.01%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG37.55% $0.31 $39B IFRXInflaRx NV-320.86% -$0.21 $54.4M -
What do Analysts Say About SMMNY or IFRX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $11.24 which suggests that it could grow by 886.3%. Given that InflaRx NV has higher upside potential than Siemens Healthineers AG, analysts believe InflaRx NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IFRXInflaRx NV5 2 0 -
Is SMMNY or IFRX More Risky?
Siemens Healthineers AG has a beta of 1.122, which suggesting that the stock is 12.17% more volatile than S&P 500. In comparison InflaRx NV has a beta of 1.459, suggesting its more volatile than the S&P 500 by 45.896%.
-
Which is a Better Dividend Stock SMMNY or IFRX?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.83%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 31.41% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IFRX?
Siemens Healthineers AG quarterly revenues are $7.4B, which are larger than InflaRx NV quarterly revenues of $27.8K. Siemens Healthineers AG's net income of $697.6M is higher than InflaRx NV's net income of -$14.3M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 24.77x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.28x versus 352.24x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.28x 24.77x $7.4B $697.6M IFRXInflaRx NV352.24x -- $27.8K -$14.3M
-
Which has Higher Returns SMMNY or IMTX?
Immatics NV has a net margin of 9.44% compared to Siemens Healthineers AG's net margin of -974.45%. Siemens Healthineers AG's return on equity of 11.65% beat Immatics NV's return on equity of -25.21%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG37.55% $0.31 $39B IMTXImmatics NV-- -$0.49 $508.8M -
What do Analysts Say About SMMNY or IMTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $18.75 which suggests that it could grow by 80.81%. Given that Immatics NV has higher upside potential than Siemens Healthineers AG, analysts believe Immatics NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IMTXImmatics NV9 0 0 -
Is SMMNY or IMTX More Risky?
Siemens Healthineers AG has a beta of 1.122, which suggesting that the stock is 12.17% more volatile than S&P 500. In comparison Immatics NV has a beta of 1.361, suggesting its more volatile than the S&P 500 by 36.134%.
-
Which is a Better Dividend Stock SMMNY or IMTX?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.83%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 31.41% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IMTX?
Siemens Healthineers AG quarterly revenues are $7.4B, which are larger than Immatics NV quarterly revenues of $6.1M. Siemens Healthineers AG's net income of $697.6M is higher than Immatics NV's net income of -$59.1M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 24.77x while Immatics NV's PE ratio is 42.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.28x versus 13.85x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.28x 24.77x $7.4B $697.6M IMTXImmatics NV13.85x 42.21x $6.1M -$59.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
